Announcements

Ann M. Kappler, an officer of Prudential Financial Inc, filed a Form 144 notice on November 6, 2026, proposing the sale of 2,919 shares of Prudential Financial common stock through broker Morgan Stanley Smith Barney LLC.

Andrew F. Sullivan, Chief Executive Officer and Chairman of the Board of Prudential Financial Inc., filed a Form 144 notice of proposed sale of 3,705 common shares on November 6, 2026, arising from the exercise of stock options granted in 2017.

J. Jefferson Smith, an officer of Precision Biosciences Inc, filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 875 shares of common stock on NASDAQ under Rule 144 of the Securities Act of 1933.

Sierra Bancorp director Lynda Scearcy filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 18,025 shares of common stock through Stifel Nicolaus & Company Inc., with an aggregate market value of $747,248.00.

aTyr Pharma, Inc. filed a current report on November 6, 2026, disclosing the submission of a prospectus supplement to the SEC covering the potential at-the-market sale of common stock with an aggregate offering price of up to $79,994,251.

Gilead Sciences Inc officer Keeley M Cain Wettan filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 3,399 shares of Gilead common stock acquired through restricted stock unit vesting.

Bowman Consulting Group Ltd. filed post-effective amendments to two Form S-3 registration statements on November 6, 2026, deregistering all remaining unsold securities following the completion of a merger that made the company a wholly-owned subsidiary of Prive Parent, Inc.